Compositions and methods for treatment of renin-angiotensin aldosterone system (RAAS)-related disorders

Details for Australian Patent Application No. 2009305619 (hide)

Owner Invasc Therapeutic, Inc.

Inventors Rajagopal, Desikan

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2009305619

PCT Pub. Number WO2010/045575

Priority 61/196,417 17.10.08 US

Filing date 16 October 2009

Wipo publication date 22 April 2010

Acceptance publication date 21 June 2012

International Classifications

C07D 207/08 Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom

A61K 31/4015 - having oxo groups directly attached to the heterocyclic ring, e.g. piracetam, ethosuximide

A61P 9/12 Drugs for disorders of the cardiovascular system

A61P 25/28 Drugs for disorders of the nervous system

C07D 207/16 Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom

C07D 409/12 Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

Event Publications

12 May 2011 PCT application entered the National Phase

  PCT publication WO2010/045575 Priority application(s): WO2010/045575

21 June 2012 Application Accepted

  Published as AU-B-2009305619

18 October 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009305623-Prosthetic implant shell

2009305618-Trolley assembly for passenger restraint system